Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies.

Noémie AbisrorMeryam CheloufiJonathan CohenAurore CoulombChloé McAvoyOlivier FainJean Luc TaupinVassilis TsatsarisGilles KayemArsenne Mekinian

Published in: American journal of reproductive immunology (New York, N.Y. : 1989) (2024)

This is the first report demonstrating the potential benefit of intravenous immunoglobulins in recurrent chronic intervillositis. Larger studies are needed to confirm this potential benefit for patients presenting severe cases of recurrent CHI.

Keyphrases

end stage renal disease
high dose
newly diagnosed
ejection fraction
chronic kidney disease
drug induced
prognostic factors
human health
early onset
low dose
risk assessment
case report
patient reported